Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial PY Benhamou, S Franc, Y Reznik, C Thivolet, P Schaepelynck, E Renard, ... The Lancet Digital Health 1 (1), e17-e25, 2019 | 183 | 2019 |
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a … S Lablanche, MC Vantyghem, L Kessler, A Wojtusciszyn, S Borot, ... The lancet Diabetes & endocrinology 6 (7), 527-537, 2018 | 161 | 2018 |
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network BPY Lablanche S1, Borot S2, Wojtusciszyn A3, Bayle F4, Tétaz R4, Badet L5 ... Diabetes Care, 2015 | 133 | 2015 |
Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D B Li, C Chauvin, D De Paulis, F De Oliveira, A Gharib, G Vial, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1817 (9), 1628-1634, 2012 | 120 | 2012 |
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial E Bosi, P Choudhary, HW De Valk, S Lablanche, J Castañeda, S De Portu, ... The lancet Diabetes & endocrinology 7 (6), 462-472, 2019 | 106 | 2019 |
Protection of pancreatic INS-1 β-cells from glucose-and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin S Lablanche, C Cottet-Rousselle, F Lamarche, PY Benhamou, S Halimi, ... Cell death & disease 2 (3), e134-e134, 2011 | 93 | 2011 |
Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag S Larcher, AS Gauchez, S Lablanche, JL Pépin, PY Benhamou, AL Borel European journal of endocrinology 175 (5), 411-419, 2016 | 80 | 2016 |
Diabeloop DBLG1 closed-loop system enables patients with type 1 diabetes to significantly improve their glycemic control in real-life situations without serious adverse events … C Amadou, S Franc, PY Benhamou, S Lablanche, E Huneker, ... Diabetes Care 44 (3), 844-846, 2021 | 62 | 2021 |
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d … A Wojtusciszyn, J Branchereau, L Esposito, L Badet, F Buron, ... Diabetes & metabolism 45 (3), 224-237, 2019 | 46 | 2019 |
Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study R Roussel, P Darmon, M Pichelin, T Goronflot, Y Abouleka, L Ait Bachir, ... Diabetes, Obesity and Metabolism 23 (5), 1162-1172, 2021 | 39 | 2021 |
Anti-donor HLA antibody response after pancreatic islet grafting: characteristics, risk factors, and impact on graft function E Pouliquen, P Baltzinger, A Lemle, CC Chen, A Parissiadis, S Borot, ... American Journal of Transplantation 17 (2), 462-473, 2017 | 36 | 2017 |
Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report S Skalli, N Wion-Barbot, M Baudrant, S Lablanche, P Benhamou, S Halimi Diabetic Medicine 27 (4), 486-487, 2010 | 31 | 2010 |
Respective effects of oxygen and energy substrate deprivation on beta cell viability S Lablanche, C Cottet-Rousselle, L Argaud, C Laporte, F Lamarche, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847 (6-7), 629-639, 2015 | 30 | 2015 |
Practical implementation of automated closed-loop insulin delivery: a French position statement N Tubiana-Rufi, P Schaepelynck, S Franc, L Chaillous, M Joubert, ... Diabetes & Metabolism 47 (3), 101206, 2021 | 26 | 2021 |
Human mesenchymal stem cells improve rat islet functionality under cytokine stress with combined upregulation of heme oxygenase-1 and ferritin C Laporte, E Tubbs, J Cristante, AS Gauchez, S Pesenti, F Lamarche, ... Stem cell research & therapy 10, 1-12, 2019 | 25 | 2019 |
Improved human islets’ viability and functionality with mesenchymal stem cells and arg-gly-asp tripeptides supplementation of alginate micro-encapsulated islets in vitro C Laporte, E Tubbs, M Pierron, A Gallego, A Moisan, F Lamarche, ... Biochemical and Biophysical Research Communications 528 (4), 650-657, 2020 | 24 | 2020 |
Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network S Lablanche, S Borot, A Wojtusciszyn, K Skaare, A Penfornis, P Malvezzi, ... American Journal of Transplantation 21 (11), 3725-3733, 2021 | 23 | 2021 |
Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed‐loop insulin delivery system: A series of N‐of‐1 randomized … PY Benhamou, S Lablanche, A Vambergue, M Doron, S Franc, ... Diabetes, Obesity and Metabolism 23 (1), 186-194, 2021 | 22 | 2021 |
A worldwide survey of activities and practices in clinical islet of Langerhans transplantation T Berney, A Andres, MD Bellin, EJP de Koning, PRV Johnson, TWH Kay, ... Transplant International 35, 10507, 2022 | 18 | 2022 |
Comprehensive characterization of the human pancreatic proteome for bioengineering applications A Asthana, R Tamburrini, D Chaimov, C Gazia, SJ Walker, M Van Dyke, ... Biomaterials 270, 120613, 2021 | 18 | 2021 |